Zobrazeno 1 - 10
of 108
pro vyhledávání: '"YIN-HSUN FENG"'
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Autor:
Joon Oh Park, Yin-Hsun Feng, Wu-Chou Su, Do-Youn Oh, Bhumsuk Keam, Lin Shen, Sang-We Kim, Xiufeng Liu, Huimin Liao, Min Qing, Chong Zhang, Jiaqi Qian, Xiaodan Tang, Peng Li, Spyros Triantos, Hussein Sweiti
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background FGFR genomic aberrations occur in approximately 5–10% of human cancers. Erdafitinib has previously demonstrated efficacy and safety in FGFR-altered advanced solid tumors, such as gliomas, thoracic, gastrointestinal, gynecologica
Externí odkaz:
https://doaj.org/article/46cf37a8f4c5475998d9519b116a314e
Publikováno v:
Neurotrauma Reports, Vol 4, Iss 1, Pp 751-760 (2023)
Mild traumatic brain injury (mTBI) is a prevalent health concern with variable recovery trajectories, necessitating reliable prognostic markers. Insulin-like growth factor 1 (IGF-1) emerges as a potential candidate because of its role in cellular gro
Externí odkaz:
https://doaj.org/article/e7e606410f6548c4a80884b44d05631f
Autor:
Jameel Muzaffar, Tae Min Kim, Julie Brahmer, Dirk G Brockstedt, Chia-Chi Lin, Michael Chisamore, Ki Hyeong Lee, Paul D Kassner, Nuttapong Ngamphaiboon, William Ho, Nicole Nasrah, Pratibha Desai, Yin-Hsun Feng, Shang-Yin Wu, Rakesh Kumar Goyal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 2 (2023)
Externí odkaz:
https://doaj.org/article/bd8985e88135407b9ef78e59280fb9c0
Publikováno v:
Asian Nursing Research, Vol 17, Iss 1, Pp 8-14 (2023)
Summary: Purpose: Dignity is a basic human right that is related to psychological distress factors in patients with cancer such as depression and demoralization. Hence, the dignity issue is of great importance to healthcare professionals. The present
Externí odkaz:
https://doaj.org/article/446b492250df4455a99b87a0c031f8a3
Autor:
Yu-Yun Shao, Yin-Hsun Feng, Chia-Jui Yen, Tsai-Sheng Yang, Ying-Chun Shen, Yee Chao, Jen-Shi Chen, Ching-Yen Su, Wei-Jen Chen, Hwa-Lin Hsiang, Chih-Hung Hsu
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 12, Pp 2430-2437 (2022)
Background: The combination of bevacizumab and atezolizumab has been established as a standard first-line systemic treatment for unresectable hepatocellular carcinoma (HCC). We examined the treatment outcomes of patients in Taiwan who received the co
Externí odkaz:
https://doaj.org/article/b516aa283916436c9db4ed35dc672f2a
Publikováno v:
Journal of the Formosan Medical Association, Vol 121, Iss 4, Pp 861-864 (2022)
COVID-19 has not only affected the respiratory but the cardiovascular system. Taiwan has encountered a less severe COVID-19 pandemic. We reported the current situation in Taiwan. In this study, we retrospectively analyzed the data from our cardio-onc
Externí odkaz:
https://doaj.org/article/68724ba30e5849cf902c83c229cda1d0
Autor:
Shukui Qin, Zhenggang Ren, Yin-Hsun Feng, Thomas Yau, Baocheng Wang, Haitao Zhao, Yuxian Bai, Shanzhi Gu, Lindong Li, Sairy Hernandez, Derek-Zhen Xu, Sohail Mulla, Yifan Wang, Hui Shao, Ann Lii Cheng
Publikováno v:
Liver Cancer, Pp 1-13 (2021)
Introduction: Atezolizumab plus bevacizumab significantly improved overall survival (OS) and progression-free survival (PFS) versus sorafenib in patients with unresectable hepatocellular carcinoma (HCC) in IMbrave150. Efficacy and safety data from th
Externí odkaz:
https://doaj.org/article/8419d086468a48ccade95457dd922afe
Autor:
Wei‐Ting Chang, Yin‐Hsun Feng, Yu Hsuan Kuo, Wei‐Yu Chen, Hong‐Chang Wu, Chien‐Tai Huang, Wen‐Ching Wang, Chia‐Te Liao, Zhih‐Cherng Chen
Publikováno v:
ESC Heart Failure, Vol 7, Iss 5, Pp 2135-2139 (2020)
Externí odkaz:
https://doaj.org/article/ea6bb9a0df894d93936fca18d161bfcf
Publikováno v:
Asian Nursing Research, Vol 14, Iss 4, Pp 189-195 (2020)
Purpose: The aim of the study was to determine the effectiveness of dignity therapy for end-of-life patients with cancer. Methods: This study used a quasi-experimental study design with a nonrandomized controlled trial. Dignity therapy was used as an
Externí odkaz:
https://doaj.org/article/d30edb658ecf46928dc9e0626ded476a
Autor:
Chia-Sing Lu, Ai-Li Shiau, Bing-Hua Su, Tsui-Shan Hsu, Chung-Teng Wang, Yu-Chu Su, Ming-Shian Tsai, Yin-Hsun Feng, Yau-Lin Tseng, Yi-Ting Yen, Chao-Liang Wu, Gia-Shing Shieh
Publikováno v:
Journal of Hematology & Oncology, Vol 13, Iss 1, Pp 1-16 (2020)
Abstract Background Expression of Oct4 maintains cancer stem cell (CSC)-like properties in lung cancer cells and is correlated with poor prognosis of lung adenocarcinoma. M2-type tumor-associated macrophages (TAMs) promote cancer cell migration and m
Externí odkaz:
https://doaj.org/article/45536201108e47df80c54e623fbce423